CRYOPORT INC (CYRX) Fundamental Analysis & Valuation

NASDAQ:CYRX • US2290503075

Current stock price

9.67 USD
-0.09 (-0.92%)
At close:
9.67 USD
0 (0%)
After Hours:

This CYRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CYRX Profitability Analysis

1.1 Basic Checks

  • CYRX had positive earnings in the past year.
  • In the past year CYRX has reported a negative cash flow from operations.
  • CYRX had negative earnings in 4 of the past 5 years.
  • CYRX had negative operating cash flow in 4 of the past 5 years.
CYRX Yearly Net Income VS EBIT VS OCF VS FCFCYRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • CYRX has a better Return On Assets (8.71%) than 89.47% of its industry peers.
  • CYRX has a better Return On Equity (13.25%) than 89.47% of its industry peers.
Industry RankSector Rank
ROA 8.71%
ROE 13.25%
ROIC N/A
ROA(3y)-6.5%
ROA(5y)-9.87%
ROE(3y)-12.85%
ROE(5y)-18.18%
ROIC(3y)N/A
ROIC(5y)N/A
CYRX Yearly ROA, ROE, ROICCYRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • CYRX's Profit Margin of 37.81% is amongst the best of the industry. CYRX outperforms 100.00% of its industry peers.
  • CYRX has a Gross Margin (47.14%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CYRX has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 37.81%
GM 47.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.49%
GM growth 5Y0.44%
CYRX Yearly Profit, Operating, Gross MarginsCYRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CYRX Health Analysis

2.1 Basic Checks

  • CYRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CYRX has about the same amount of shares outstanding.
  • The number of shares outstanding for CYRX has been increased compared to 5 years ago.
  • CYRX has a better debt/assets ratio than last year.
CYRX Yearly Shares OutstandingCYRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CYRX Yearly Total Debt VS Total AssetsCYRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CYRX has an Altman-Z score of 0.32. This is a bad value and indicates that CYRX is not financially healthy and even has some risk of bankruptcy.
  • CYRX has a worse Altman-Z score (0.32) than 66.67% of its industry peers.
  • CYRX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.00, CYRX is doing good in the industry, outperforming 71.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC9.45%
CYRX Yearly LT Debt VS Equity VS FCFCYRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CYRX has a Current Ratio of 2.17. This indicates that CYRX is financially healthy and has no problem in meeting its short term obligations.
  • CYRX has a Current ratio of 2.17. This is comparable to the rest of the industry: CYRX outperforms 43.86% of its industry peers.
  • A Quick Ratio of 2.07 indicates that CYRX has no problem at all paying its short term obligations.
  • CYRX has a Quick ratio of 2.07. This is comparable to the rest of the industry: CYRX outperforms 47.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.07
CYRX Yearly Current Assets VS Current LiabilitesCYRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CYRX Growth Analysis

3.1 Past

  • CYRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 213.79%, which is quite impressive.
  • CYRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.86%.
  • CYRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.49% yearly.
EPS 1Y (TTM)213.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.71%
Revenue 1Y (TTM)-22.86%
Revenue growth 3Y-9.45%
Revenue growth 5Y17.49%
Sales Q2Q%-23.65%

3.2 Future

  • CYRX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.25% yearly.
  • Based on estimates for the next years, CYRX will show a quite strong growth in Revenue. The Revenue will grow by 8.52% on average per year.
EPS Next Y-158.16%
EPS Next 2Y-58.35%
EPS Next 3Y-33.33%
EPS Next 5Y-17.25%
Revenue Next Year10.47%
Revenue Next 2Y9.46%
Revenue Next 3Y9.74%
Revenue Next 5Y8.52%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CYRX Yearly Revenue VS EstimatesCYRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
CYRX Yearly EPS VS EstimatesCYRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. CYRX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.33 indicates a rather cheap valuation of CYRX.
  • 100.00% of the companies in the same industry are more expensive than CYRX, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.78. CYRX is valued rather cheaply when compared to this.
  • The Forward Price/Earnings Ratio is negative for CYRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 7.33
Fwd PE N/A
CYRX Price Earnings VS Forward Price EarningsCYRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYRX Per share dataCYRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as CYRX's earnings are expected to decrease with -33.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.35%
EPS Next 3Y-33.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CYRX Dividend Analysis

5.1 Amount

  • CYRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CYRX Fundamentals: All Metrics, Ratios and Statistics

CRYOPORT INC

NASDAQ:CYRX (4/10/2026, 8:15:31 PM)

After market: 9.67 0 (0%)

9.67

-0.09 (-0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-03
Earnings (Next)04-30
Inst Owners98.81%
Inst Owner Change0.11%
Ins Owners4.04%
Ins Owner Change5.65%
Market Cap482.15M
Revenue(TTM)176.18M
Net Income(TTM)66.61M
Analysts85
Price Target13.77 (42.4%)
Short Float %4.72%
Short Ratio5.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.18%
Min EPS beat(2)-28.77%
Max EPS beat(2)16.41%
EPS beat(4)3
Avg EPS beat(4)239.3%
Min EPS beat(4)-28.77%
Max EPS beat(4)957.28%
EPS beat(8)5
Avg EPS beat(8)127.06%
EPS beat(12)7
Avg EPS beat(12)51.69%
EPS beat(16)7
Avg EPS beat(16)30.75%
Revenue beat(2)2
Avg Revenue beat(2)4.34%
Min Revenue beat(2)3.81%
Max Revenue beat(2)4.86%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)6.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.68%
Revenue beat(12)3
Avg Revenue beat(12)-1.37%
Revenue beat(16)4
Avg Revenue beat(16)-2.27%
PT rev (1m)2.1%
PT rev (3m)2.1%
EPS NQ rev (1m)-2.27%
EPS NQ rev (3m)-19.58%
EPS NY rev (1m)-9.08%
EPS NY rev (3m)-9.28%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)1.24%
Revenue NY rev (3m)1.57%
Valuation
Industry RankSector Rank
PE 7.33
Fwd PE N/A
P/S 2.74
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)1.32
EY13.65%
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS3.53
BVpS10.08
TBVpS6.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number17.3
Profitability
Industry RankSector Rank
ROA 8.71%
ROE 13.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 37.81%
GM 47.14%
FCFM N/A
ROA(3y)-6.5%
ROA(5y)-9.87%
ROE(3y)-12.85%
ROE(5y)-18.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.49%
GM growth 5Y0.44%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.38%
Cap/Sales 11.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 2.07
Altman-Z 0.32
F-Score5
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)100.96%
Cap/Depr(5y)106.53%
Cap/Sales(3y)17.09%
Cap/Sales(5y)14.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)213.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.71%
EPS Next Y-158.16%
EPS Next 2Y-58.35%
EPS Next 3Y-33.33%
EPS Next 5Y-17.25%
Revenue 1Y (TTM)-22.86%
Revenue growth 3Y-9.45%
Revenue growth 5Y17.49%
Sales Q2Q%-23.65%
Revenue Next Year10.47%
Revenue Next 2Y9.46%
Revenue Next 3Y9.74%
Revenue Next 5Y8.52%
EBIT growth 1Y45.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.04%
EBIT Next 3Y34.22%
EBIT Next 5Y25%
FCF growth 1Y25.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.44%
OCF growth 3YN/A
OCF growth 5YN/A

CRYOPORT INC / CYRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CRYOPORT INC (CYRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CYRX.


What is the valuation status of CRYOPORT INC (CYRX) stock?

ChartMill assigns a valuation rating of 2 / 10 to CRYOPORT INC (CYRX). This can be considered as Overvalued.


How profitable is CRYOPORT INC (CYRX) stock?

CRYOPORT INC (CYRX) has a profitability rating of 3 / 10.


What are the PE and PB ratios of CRYOPORT INC (CYRX) stock?

The Price/Earnings (PE) ratio for CRYOPORT INC (CYRX) is 7.33 and the Price/Book (PB) ratio is 0.96.


What is the earnings growth outlook for CRYOPORT INC?

The Earnings per Share (EPS) of CRYOPORT INC (CYRX) is expected to decline by -158.16% in the next year.